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ABSTRACT 
BACKGROUND: 
        A common complication associated with chemoradiotherapy in the oral 
mucosa is oral mucositis, worsening the patient’s quality of life and has a 
negative influence on the treatment outcome. Approximately 60% of patients 
receiving conventional radiotherapy and more than 90% of patients submitted 
to combined therapy (concomitant chemotherapy and radiotherapy) develop 
severe oral mucositis. L-Glutamine is a conditionally essential amino acid 
critical to the regulation of protein synthesis, cellular energy, respiratory 
fuelling. Patients undergoing chemoradiotherapy for cancer have marked 
glutamine depletion. This can have a negative impact on the function of host 
tissues that are dependent upon adequate stores of glutamine for optimal 
functioning. 
        Glutathione, an antioxidant is a by-product of glutamine metabolism is an 
antagonist to prostaglandin E (PGE) production, which is an inflammatory 
mediator. These facts suggest a possible therapeutic role for glutamine in the 
prevention of host normal tissue toxicity during cancer treatment. The present 
study was conducted to study the efficacy of L-Glutamine in the management 
of acute radiation induced mucositis in head and neck cancer patients. 
 
 
 
AIM AND OBJECTIVES: 
        To evaluate the efficacy of L-Glutamine in the management of acute 
radiation induced mucositis in head and neck cancer patients undergoing 
chemoradiotherapy. To evaluate the grades of oral mucositis in patients 
undergoing chemoradiotherapy in Glutamine group and control group. To 
assess the time of onset of oral mucositis in the study group and control group. 
To evaluate subject benefit of relief of pain between the 2 groups. 
METHODOLOGY: 
        The study consists of 50 patients divided into 2 groups. Group I consists 
of control group where 25 patients undergoing chemoradiotherapy for head 
and neck cancer use normal saline mouthwash three times daily throughout 
radiotherapy treatment. Group II consists of study group where 25 patients 
undergoing chemoradiotherapy are given 10g L-Glutamine crystalline powder 
to be mixed in 200mL of water and to be consumed 2 hours before 
radiotherapy from the beginning till end of radiotherapy on the days of 
treatment. The mucositis was graded using WHO scale and pain was scored 
using Numeric Rating Scale. 
RESULTS: 
         The results showed there was significant reduction in the maximum 
mucositis grading between the control group and glutamine group. There was 
significant delay in onset of severe mucositis and reduction in pain score when 
glutamine was used. 
 
CONCLUSION: 
        Glutamine significantly reduced the severity and delays the onset of 
mucositis and can be used in the management of acute radiation induced 
mucositis. 
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